Acquired Resistance Mechanisms to Combination Met-TKI/EGFR-TKI Exposure in Met-Amplified EGFR-TKI–Resistant Lung Adenocarcinoma Harboring an Activating EGFR MutationToshimitsu Yamaoka, Yasutsuna Sasaki|Molecular Cancer Therapeutics|2016Cited by 29